Literature DB >> 18349748

Lifestyle and gout.

A Elisabeth Hak1, Hyon K Choi.   

Abstract

PURPOSE OF REVIEW: This review summarizes recent epidemiologic research findings on gout, and attempts to put them into the context of clinical and public health decision-making aimed at prevention and improved management of gout. RECENT
FINDINGS: A large prospective study found that coffee consumption was inversely associated with risk of gout and that consumption of sugar-sweetened soft drinks or fructose was strongly associated with an increased gout risk. Studies based on the Third National Health and Nutrition Examination Survey (NHANES III) suggest that these consumptions affect serum uric acid levels parallel to the direction of gout risk. Furthermore, data from NHANES III show a remarkably high prevalence of the metabolic syndrome among individuals with gout. Prospective studies found an increased risk of myocardial infarction and cardiovascular mortality in gout patients.
SUMMARY: Lifestyle and dietary recommendations for gout patients should consider other health benefits, since gout is often associated with major chronic disorders such as the metabolic syndrome and an increased risk for cardiovascular disease and mortality. In addition to recent dietary recommendations, gout patients should be advised to limit fructose intake. The inverse link between coffee and the risk of gout suggests that coffee could be allowed among gout patients.

Entities:  

Mesh:

Year:  2008        PMID: 18349748     DOI: 10.1097/BOR.0b013e3282f524a2

Source DB:  PubMed          Journal:  Curr Opin Rheumatol        ISSN: 1040-8711            Impact factor:   5.006


  19 in total

1.  [Asymptomatic nodule on an elderly lady's thumb tip].

Authors:  M Felcht; J Faulhaber; A Schmieder; W Koenen; S Goerdt; M Goebeler
Journal:  Hautarzt       Date:  2011-03       Impact factor: 0.751

2.  Interactions between genetic variants in glucose transporter type 9 (SLC2A9) and dietary habits in serum uric acid regulation.

Authors:  Iris Jeroncić; Rosanda Mulić; Zorana Klismanić; Diana Rudan; Mladen Boban; Lina Zgaga
Journal:  Croat Med J       Date:  2010-02       Impact factor: 1.351

Review 3.  Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases.

Authors:  Bharat B Aggarwal; Kuzhuvelil B Harikumar
Journal:  Int J Biochem Cell Biol       Date:  2008-07-09       Impact factor: 5.085

4.  The urate-lowering efficacy and safety of febuxostat in the treatment of the hyperuricemia of gout: the CONFIRMS trial.

Authors:  Michael A Becker; H Ralph Schumacher; Luis R Espinoza; Alvin F Wells; Patricia MacDonald; Eric Lloyd; Christopher Lademacher
Journal:  Arthritis Res Ther       Date:  2010-04-06       Impact factor: 5.156

Review 5.  Update on gout: new therapeutic strategies and options.

Authors:  Robert Terkeltaub
Journal:  Nat Rev Rheumatol       Date:  2010-01       Impact factor: 20.543

6.  Hydroxylated chalcones with dual properties: Xanthine oxidase inhibitors and radical scavengers.

Authors:  Emily Hofmann; Jonathan Webster; Thuy Do; Reid Kline; Lindsey Snider; Quintin Hauser; Grace Higginbottom; Austin Campbell; Lili Ma; Stefan Paula
Journal:  Bioorg Med Chem       Date:  2015-12-17       Impact factor: 3.641

7.  Gouty arthritis: the diagnostic and therapeutic impact of dual-energy CT.

Authors:  Tim Finkenstaedt; Andrei Manoliou; Martin Toniolo; Kai Higashigaito; Gustav Andreisek; Roman Guggenberger; Beat Michel; Hatem Alkadhi
Journal:  Eur Radiol       Date:  2016-02-04       Impact factor: 5.315

Review 8.  Scientific evidence and rationale for the development of curcumin and resveratrol as nutraceutricals for joint health.

Authors:  Ali Mobasheri; Yves Henrotin; Hans-Konrad Biesalski; Mehdi Shakibaei
Journal:  Int J Mol Sci       Date:  2012-03-30       Impact factor: 6.208

9.  New and improved strategies for the treatment of gout.

Authors:  Natalie Dubchak; Gerald F Falasca
Journal:  Int J Nephrol Renovasc Dis       Date:  2010-11-24

10.  Febuxostat in the management of hyperuricemia and chronic gout: a review.

Authors:  Miao Hu; Brian Tomlinson
Journal:  Ther Clin Risk Manag       Date:  2008-12       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.